+441423330085
Reviews 1

I have been using Action pharma products for a few months now, and I am extremely satisfied. Their products have made a noticeable difference in my health, and I appreciate the quality and attention to detail. Highly recommended!

Kevin Diaz
Reviews 1

I've been a loyal customer of Action pharma for a while now and I can't say enough good things about them. Their products are top quality and their customer service is exceptional. They always go above and beyond to ensure customer satisfaction.

Robert Reynolds
Reviews 1

🌟 Action pharma is absolutely fantastic! I've tried many different products from various companies, but none have matched the quality and effectiveness of Action pharma. Their website is easy to navigate and their prices are competitive. Highly recommended!

Celia Bozsum
Reviews 1

Action pharma is an average company. They have a decent range of products and their website is easy to navigate. However, I found their customer service to be a bit lacking. Overall, it's not a bad experience, but there's definitely room for improvement.

News & Press

No news yet. This is where the business shares its own updates and press.

Photos

No photos yet. Photos shared by reviewers will show up here.

Widgets

Boost your business trust by displaying widget on your website — its a simple way to convert your visitors into customers.

Embed code

<script src="https://trustburn.com/widgets/index.js"></script>
<div class="trustburn-widget" data-trustburn-protocol="https:" data-trustburn-domain="trustburn.com" data-trustburn-widget="score" data-company-path="action-pharma" data-lang="en"></div>
More widgets

About Action pharma

Action Pharma A/S operates as a research and development focused biotechnology company. It discovers and develops new drugs and treatment concepts to treat cardiovascular disease and inflammatory diseases, as well as metabolic diseases, such as type-II diabetes and obesity. The company's product pipeline includes AP214, a modified ÐMSH-peptide analogue for the treatment of post-surgical kidney injury associated with cardiac surgery; and AP1030 and AP11 series, oral anti-diabetic (OAD) for the treatment of type-II diabetes associated with overweight/obesity. Its product pipeline also comprise AP1189, an oral anti-inflammatory compound for the treatment of inflammatory diseases, such as inflammatory bowel disease and rheumatoid arthritis; and AP405, a modified MSH peptide analogue for the treatment of inflammatory skin diseases, such as atopic dermatitis. The company was founded in 2000 and is based in Holte, Denmark.

Categories
Biotechnology